Laura W Goff Selected Research

Laura W Goff Research Topics

Disease

17	Neoplasms (Cancer) 06/2023 - 10/2008
6	Biliary Tract Neoplasms (Biliary Tract Cancer) 06/2023 - 09/2013
5	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 06/2011
4	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 05/2009
4	Nausea 01/2019 - 02/2012
3	Thrombocytopenia (Thrombopenia) 12/2021 - 01/2016
3	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2020 - 12/2018
3	Fatigue 01/2019 - 01/2016
2	Adenocarcinoma 12/2019 - 12/2010
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2018 - 01/2018
2	Neutropenia 01/2018 - 02/2012
2	Neoplasm Metastasis (Metastasis) 11/2012 - 12/2010
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2022
1	Exanthema (Rash) 12/2021
1	Necrosis 01/2020
1	Carcinoma (Carcinomatosis) 12/2019
1	Cholangiocarcinoma 12/2019
1	Chromosomal Instability (Chromosome Stability) 01/2019
1	Vomiting 01/2019
1	Dehydration (Water Stress) 01/2019
1	Leukopenia 01/2018
1	Lymphopenia (Lymphocytopenia) 01/2018
1	Anemia 01/2018
1	Rectal Neoplasms (Rectal Cancer) 01/2018
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2016
1	Melanoma (Melanoma, Malignant) 12/2016
1	Clinical Deterioration 06/2014
1	Diarrhea 02/2012
1	Leukemia 12/2010
1	Hematologic Neoplasms (Hematological Malignancy) 02/2010
1	Aneuploidy (Aneuploid) 02/2010

Drug/Important Bio-Agent (IBA)

4	Immune Checkpoint InhibitorsIBA 06/2023 - 01/2020
4	Gemcitabine FDA Link 12/2019 - 01/2017
3	Biomarkers (Surrogate Marker)IBA 06/2023 - 04/2014
3	Aurora Kinase AIBA 01/2019 - 02/2010
2	PlatinumIBA 12/2019 - 01/2019
2	MLN 8237IBA 01/2019 - 12/2018
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2018 - 01/2017
2	Irinotecan (Camptosar)FDA LinkGeneric 02/2012 - 10/2008
2	Aurora KinasesIBA 12/2010 - 02/2010
1	InterferonsIBA 01/2023
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 01/2023
1	pembrolizumabIBA 01/2023
1	epacadostatIBA 01/2023
1	Azacitidine (5 Azacytidine)FDA Link 01/2023
1	EnzymesIBA 01/2023
1	Radioisotopes (Radionuclides)IBA 01/2022
1	Peptide Receptors (Peptide Receptor)IBA 01/2022
1	Glutamine (L-Glutamine)FDA Link 01/2022
1	atezolizumabIBA 12/2021
1	cobimetinibIBA 12/2021
1	LigandsIBA 12/2021
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2021
1	B7-H1 AntigenIBA 12/2021
1	AntibodiesIBA 01/2020
1	NivolumabIBA 01/2020
1	Programmed Cell Death 1 ReceptorIBA 01/2020
1	130-nm albumin-bound paclitaxelIBA 01/2019
1	Cisplatin (Platino)FDA LinkGeneric 01/2019
1	Alanine Transaminase (SGPT)IBA 01/2018
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2018
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2018
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	Dasatinib (BMS 354825)FDA Link 01/2018
1	STA 9090IBA 01/2018
1	Cytotoxins (Cytolysins)IBA 01/2018
1	linifanibIBA 01/2017
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2017
1	Monoclonal AntibodiesIBA 01/2016
1	Activin Receptors (Activin Receptor)IBA 01/2016
1	Amylases FDA Link 01/2016
1	Lipase (Acid Lipase)FDA Link 01/2016
1	ascrinvacumabIBA 01/2016
1	Antineoplastic Agents (Antineoplastics)IBA 01/2016
1	MicroRNAs (MicroRNA)IBA 04/2014
1	Thymidylate SynthaseIBA 01/2014
1	Capecitabine (Xeloda)FDA Link 02/2012
1	AZD 6244IBA 06/2011
1	Mitogen-Activated Protein Kinase 1 (p42 MAP Kinase)IBA 06/2011
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2010
1	ErbB Receptors (EGF Receptor)IBA 12/2010
1	Insulin-Like PeptidesIBA 10/2010
1	Epirubicin (Ellence)FDA LinkGeneric 10/2008

Therapy/Procedure

17	Therapeutics 01/2023 - 02/2010
8	Drug Therapy (Chemotherapy) 12/2019 - 05/2009
5	Immunotherapy 06/2023 - 05/2009
1	Liver Transplantation 01/2020
1	Pancreaticoduodenectomy 12/2019